Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.8.0.1
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions [Table Text Block]
The fair value associated with the market award vesting was determined utilizing a binomial valuation methodology and the following assumptions:
 
 
 
September 30, 2017
 
Risk-free interest rate
 
 
1.81% - 2.38
%
Exercise Price
 
$
5.73
 
Expected term in years
 
 
5.5 - 10.0
 
Expected volatility
 
 
77.3
%
Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes stock option activities for the nine months ended September 30, 2017:
 
 
 
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
 
 
 
 
Remaining
 
 
 
 
 
 
Weighted Average
 
 
Contractual Life (in
 
 
 
Stock Options
 
 
Exercise Price
 
 
years)
 
Nonvested at December 31, 2016
 
 
-
 
 
$
-
 
 
 
-
 
Options granted
 
 
1,241,675
 
 
 
5.73
 
 
 
9.56
 
Options outstanding
 
 
1,241,675
 
 
 
5.73
 
 
 
9.56
 
Options vested and exercisable at September 30, 2017
 
 
-
 
 
$
-
 
 
 
-
 
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2017 (in thousands).
 
 
 
For the three months ended September 30,
 
 
For the nine months ended September 30,
 
 
 
2017
 
 
2016
 
 
2017
 
 
2016
 
Employee
 
$
576
 
 
$
-
 
 
$
909
 
 
$
-
 
Non-employee
 
 
258
 
 
 
-
 
 
 
321
 
 
 
-
 
Total stock-based compensation expense
 
$
834
 
 
$
-
 
 
$
1,230
 
 
$
-
 
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
A summary of warrant activities for nine months ended September 30, 2017 is presented below:
 
 
 
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
 
 
 
 
Remaining
 
 
 
 
 
 
Weighted Average
 
 
Contractual Life (in
 
 
 
Warrants
 
 
Exercise Price
 
 
years)
 
Outstanding as of December 31, 2016
 
 
2,243,664
 
 
$
7.98
 
 
 
5.16
 
Granted
 
 
3,013,770
 
 
 
8.50
 
 
 
4.34
 
Outstanding as of September 30, 2017
 
 
5,257,434
 
 
$
8.28
 
 
 
4.37
 
Restricted Stock [Member]  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
The following table summarizes restricted stock award activities for the nine months ended September 30, 2017:
 
 
 
 
 
Weighted Average
 
 
 
Number of Shares
 
Grant Date Fair Value
 
Nonvested at December 31, 2016
 
 
-
 
$
-
 
Granted
 
 
180,000
 
 
5.73
 
Nonvested at September 30, 2017
 
 
180,000
 
$
5.73
 
Restricted Stock Units (RSUs) [Member]  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
The following table summarizes restricted stock units activities for the nine months ended September 30, 2017:
 
 
 
 
 
 
Weighted Average
 
 
 
Number of Units
 
Grant Date Fair Value
 
Nonvested at December 31, 2016
 
 
-
 
$
-
 
Granted
 
 
110,000
 
 
5.73
 
Nonvested at September 30, 2017
 
 
110,000
 
$
5.73